Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Authors: Laween Uthman, Anna Homayr, Rio P. Juni, Eva L. Spin, Raphaela Kerindongo, Marleen Boomsma, Markus W. Hollmann, Benedikt Preckel, Pieter Koolwijk, Victor W.M. van Hinsbergh, Coert J. Zuurbier, Martin Albrecht, Nina C. Weber

Source: Cellular Physiology and Biochemistry, Vol 53, Iss 5, Pp 865-886 (2019)

Subject Terms: Physiology, QP1-981, Biochemistry, QD415-436

File Description: electronic resource

Relation: https://www.cellphysiolbiochem.com/Articles/000178/; https://doaj.org/toc/1015-8987

Access URL: https://doaj.org/article/233c649f9b894beab1e1f03e1375d2bb